Sean McClain, Absci CEO

Mer­ck revs up deal­mak­ing en­gine ahead of #JPM22, ink­ing col­lab­o­ra­tions with AI pro­tein de­sign play­er Ab­sci

In the year-plus since Roger Perl­mut­ter left his post lead­ing Mer­ck’s R&D ef­forts, the Big Phar­ma’s new lead­er­ship has con­tin­ued to pur­sue an ag­gres­sive …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.